Biomarkers in Clinical Drug Development
John Bloom, Richard A. Dean
CRC Press, May 20, 2003 - Medical - 304 pages
Presenting applications in clinical development, pharmacokinetic/ pharmacodynamic modelling and clinical trial simulation, this reference studies the role of biomarkers in successful drug formulation and development.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
action potential analysis analytical animal application arrhythmias assessment associated beneﬁt bioanalytical biological biomarker assay biomarker concentrations biomarker data biomarker research calibration cancer cardiac repolarization cell Clin clinical drug development clinical endpoint clinical laboratory clinical research clinical trials coefﬁcient contract research organizations database deﬁned deﬁnitive diagnostic disease documentation dose drug concentrations drug development edited electronic ensure evaluation example ﬁrst gene genome HER2 human identiﬁed imaging inﬂuence investigator liarozole long QT syndrome measure methods monitoring multiple mutations novel biomarkers organizations osteoarthritis partnerships patients performance pharmaceutical pharmacogenomics Pharmacol phase PK/PD modeling polymorphisms population preclinical predict prestudy validation proﬁle protein proteomics QT interval quantiﬁcation receptor reﬂect regulatory repolarization samples scientiﬁc serum signiﬁcant speciﬁc specimen sponsor standard strategies sufﬁcient surrogate endpoints surrogate marker target techniques testing therapeutic therapy tissue torsade de pointes toxicity troglitazone tumor ventricular